The programme focuses on US-based health ventures, which does not align with the applicant's Nigeria-first and Africa-focused approach. However, the programme's focus on healthtech and improving healthcare accessibility could still be relevant. The applicant's PCN license and regulatory expertise may not be fully leveraged in a US-focused programme.